Emtora Biosciences
www.emtorabio.comEmtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and dosing clinical trial is underway in early stage prostate cancer patients. A pilot efficacy study in Familial Adenomatous Polyposis (FAP) is planned for late 2019.
Read more
Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and dosing clinical trial is underway in early stage prostate cancer patients. A pilot efficacy study in Familial Adenomatous Polyposis (FAP) is planned for late 2019.
Read more
Country
State
Texas
City (Headquarters)
San Antonio
Industry
Employees
1-10
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Planning and Operations
Email ****** @****.comPhone (***) ****-****
Technologies
(2)
Reach decision makers at Emtora Biosciences
Free credits every month!
Emtora Biosciences FAQ
San Antonio, United States
Biotechnology Research
